Iulia Giuroiu, MD
Hematology/Oncology · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · El Camino Health Medical Network LLC · 202 clinicians in this group
Hospitals listed: Alta Bates Summit Medical Center - Alta Bates Camp · El Camino Health · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Giuroiu’s office at (408) 866-4070 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence A155292 · Current
Licensed to practise in California · since 2018 · expires 2028-03-31 · David Geffen School of Medicine at UCLA.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$35,087
Medicare paid this office $35,087 for 228 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 73 | $12,187 | $76 |
| Short return visit (20+ min) | 71 | $4,409 | $47 |
| Long return visit (40+ min) | 17 | $2,606 | $124 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $2,552 | $116 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $2,233 | $70 |
See all 9 services
| Return visit (30+ min) | 73 | $12,187 | $76 |
| Short return visit (20+ min) | 71 | $4,409 | $47 |
| Long return visit (40+ min) | 17 | $2,606 | $124 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $2,552 | $116 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $2,233 | $70 |
| New patient visit (45+ min) | 12 | $1,459 | $122 |
| New patient visit (30+ min) | 18 | $1,324 | $74 |
| Return visit (30+ min) | 13 | $1,324 | $88 |
| New patient visit (45+ min) | 11 | $1,203 | $109 |
Who their Medicare patients are
228 Original Medicare patients in 2024. Average age 75 · Under 65 8% · 85 and older 18% · Women 59% · Also on Medicaid 30% · Health risk score 1.90. At or below the middle of the specialty; the typical hematology-oncology clinician is at 2.04.
Conditions among them: High blood pressure 72% · Cancer 57% · Chronic kidney disease 30% · Diabetes 26% · Coronary heart disease 24% · Heart failure 21% · Atrial fibrillation 21% · Depression 20% · COPD 18% · Dementia 10% · Stroke 10%.
The office billed $166,884, Medicare allowed $47,925 and paid $35,087; for 443 services of 18 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 228 | 443 | 75 | 1.90 | $166,884 | $35,087 |
| 2023 | 216 | 606 | 74 | 1.85 | $207,978 | $48,983 |
| 2022 | 199 | 602 | 75 | 2.23 | $196,113 | $47,967 |
| 2021 | 190 | 597 | 74 | 2.49 | $191,211 | $48,744 |
| 2020 | 223 | 793 | 74 | 2.46 | $237,547 | $54,695 |
| 2019 | 203 | 780 | 73 | 2.99 | $219,014 | $49,141 |
| 2018 | 54 | 133 | 73 | 1.98 | $41,379 | $9,780 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Return visit (30+ min) | 80 | $16,050 | $80 |
| Short return visit (20+ min) | 83 | $8,044 | $54 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 40 | $7,519 | $72 |
| Long return visit (40+ min) | 32 | $5,697 | $129 |
| New patient visit (45+ min) | 37 | $4,216 | $114 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 25 | $2,942 | $118 |
2022: 10 services
| Return visit (30+ min) | 76 | $15,835 | $82 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 54 | $7,805 | $64 |
| Short return visit (20+ min) | 71 | $7,365 | $55 |
| Long return visit (40+ min) | 23 | $4,769 | $129 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,499 | $179 |
| New patient visit (45+ min) | 19 | $2,308 | $121 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $2,117 | $92 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,332 | $121 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 15 | $1,323 | $88 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 12 | $547 | $34 |
2021: 9 services
| Return visit (30+ min) | 84 | $19,478 | $83 |
| Long return visit (40+ min) | 31 | $7,370 | $132 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 49 | $6,625 | $65 |
| Short return visit (20+ min) | 47 | $3,312 | $51 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $3,268 | $91 |
| New patient visit (45+ min) | 20 | $2,350 | $117 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,716 | $123 |
| Telephone medical discussion with physician, 11-20 minutes | 12 | $670 | $52 |
| Telephone medical discussion with physician, 5-10 minutes | 12 | $427 | $27 |
2020: 9 services
| Return visit (30+ min) | 82 | $18,361 | $70 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 86 | $11,327 | $65 |
| Short return visit (20+ min) | 66 | $5,673 | $40 |
| Long return visit (40+ min) | 32 | $4,641 | $101 |
| New patient visit (45+ min) | 35 | $3,942 | $113 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 37 | $3,659 | $96 |
| New patient visit (60+ min) | 19 | $2,879 | $152 |
| Telephone medical discussion with physician, 11-20 minutes | 23 | $1,336 | $46 |
| Telephone medical discussion with physician, 5-10 minutes | 12 | $322 | $23 |
2019: 9 services
| Short return visit (20+ min) | 82 | $12,132 | $45 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 97 | $12,103 | $64 |
| Return visit (30+ min) | 48 | $7,486 | $70 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $5,519 | $92 |
| New patient visit (45+ min) | 44 | $5,005 | $114 |
| Long return visit (40+ min) | 15 | $1,674 | $98 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,569 | $121 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 21 | $866 | $35 |
| Short return visit | 24 | $803 | $22 |
2018: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $3,520 | $93 |
| Short return visit (20+ min) | 21 | $1,642 | $46 |
| New patient visit (45+ min) | 12 | $1,369 | $114 |
Medicaid work
$346 in 2024
Medicaid paid $346 for 32 billed services this clinician did in 2024, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 32 | $346 |
| 2024 | 32 | 1 | 14 | $346 |
| 2023 | 125 | 1 | 19 | $493 |
| 2022 | 78 | 1 | 17 | $1,660 |
| 2021 | 96 | 1 | 20 | $2,156 |
| 2020 | 88 | 1 | 21 | $3,847 |
| 2019 | 38 | 1 | 13 | $902 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 125 | $493 |
2022
| Return visit (30+ min) | 78 | $1,660 |
2021
| Return visit (30+ min) | 96 | $2,156 |
2020
| Return visit (30+ min) | 88 | $3,847 |
2019
| Short return visit (20+ min) | 38 | $902 |
Drugs they prescribed that Part D paid
$299,619
Pharmacies billed $299,619 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 5% of their Part D prescriptions (23 of 462) in 2024. At or below the middle of the specialty; the typical hematology-oncology clinician is at 5%.
394 generic and 68 brand-name prescriptions · $299,619 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Abiraterone Acetate | 39 | $58,134 | $1,491 |
| Eliquis | 30 | $23,305 | $777 |
| Anastrozole | 50 | $1,042 | $21 |
| Tamoxifen Citrate | 31 | $809 | $26 |
| Hydrocodone-Acetaminophen | 17 | $423 | $25 |
See all 10 drugs
| Abiraterone Acetate | 39 | $58,134 | $1,491 |
| Eliquis | 30 | $23,305 | $777 |
| Anastrozole | 50 | $1,042 | $21 |
| Tamoxifen Citrate | 31 | $809 | $26 |
| Hydrocodone-Acetaminophen | 17 | $423 | $25 |
| Prochlorperazine Maleate | 23 | $284 | $12 |
| Prednisone | 42 | $247 | $6 |
| Tamsulosin | 12 | $159 | $13 |
| Ondansetron | 17 | $112 | $7 |
| Levothyroxine | 14 | $40 | $3 |
Year by year
| 2024 | 462 | 91 | 5% (23) | 15% | $299,619 |
| 2023 | 661 | 107 | 8% (50) | None | $619,553 |
| 2022 | 362 | 78 | 9% (34) | None | $537,318 |
| 2021 | 461 | 82 | 8% (38) | 22% | $867,112 |
| 2020 | 623 | 89 | 13% (78) | 22% | $1,159,979 |
| 2019 | 349 | 60 | 13% (44) | None | $406,749 |
| 2018 | 50 | 12 | None | None | $2,616 |
| 2017 | 83 | 16 | None | 14% | $112,608 |
| 2016 | 108 | 20 | None | 10% | $87,210 |
| 2015 | 85 | 18 | None | None | $73,762 |
| 2014 | 215 | 15 | 0% (0) | 13% | $10,063 |
| 2013 | 197 | 34 | 0% (0) | None | $14,595 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Abiraterone Acetate | 15 | $41,420 | $2,761 |
| Eliquis | 36 | $22,569 | $627 |
| Anastrozole | 62 | $1,357 | $22 |
| Hydrocodone-Acetaminophen | 30 | $888 | $30 |
| Sucralfate | 11 | $786 | $71 |
| Potassium Chloride | 20 | $767 | $38 |
| Tamoxifen Citrate | 29 | $760 | $26 |
| Prochlorperazine Maleate | 47 | $688 | $15 |
| Ondansetron | 36 | $540 | $15 |
| Dexamethasone | 19 | $534 | $28 |
| Mirtazapine | 12 | $484 | $40 |
| Prednisone | 22 | $259 | $12 |
| Famotidine | 12 | $83 | $7 |
| Trazodone | 13 | $43 | $3 |
2022: 11 drugs
| Tagrisso | 11 | $188,059 | $17,096 |
| Abiraterone Acetate | 21 | $25,581 | $1,218 |
| Eliquis | 28 | $17,578 | $628 |
| Hydrocodone-Acetaminophen | 22 | $949 | $43 |
| Anastrozole | 40 | $732 | $18 |
| Tamoxifen Citrate | 18 | $524 | $29 |
| Ondansetron | 18 | $336 | $19 |
| Prochlorperazine Maleate | 25 | $307 | $12 |
| Prednisone | 26 | $227 | $9 |
| Mirtazapine | 18 | $217 | $12 |
| Potassium Chloride | 15 | $142 | $9 |
2021: 13 drugs
| Xtandi | 14 | $173,490 | $12,392 |
| Abiraterone Acetate | 27 | $102,273 | $3,788 |
| Eliquis | 15 | $8,327 | $555 |
| Exemestane | 18 | $1,699 | $94 |
| Tamoxifen Citrate | 22 | $980 | $45 |
| Ondansetron | 23 | $696 | $30 |
| Potassium Chloride | 19 | $618 | $33 |
| Anastrozole | 13 | $361 | $28 |
| Prochlorperazine Maleate | 31 | $357 | $12 |
| Hydrocodone-Acetaminophen | 12 | $287 | $24 |
| Prednisone | 31 | $190 | $6 |
| Amlodipine Besylate | 11 | $107 | $10 |
| Trazodone | 12 | $66 | $6 |
2020: 20 drugs
| Lynparza | 19 | $287,673 | $15,141 |
| Xtandi | 18 | $213,681 | $11,871 |
| Ibrance | 15 | $203,670 | $13,578 |
| Abiraterone Acetate | 30 | $136,189 | $4,540 |
| Xarelto | 13 | $6,637 | $511 |
| Eliquis | 12 | $6,620 | $552 |
| Creon | 15 | $4,700 | $313 |
| Exemestane | 11 | $2,791 | $254 |
| Hydrocodone-Acetaminophen | 41 | $990 | $24 |
| Ondansetron | 45 | $865 | $19 |
| Tamoxifen Citrate | 18 | $826 | $46 |
| Prochlorperazine Maleate | 66 | $775 | $12 |
| Anastrozole | 21 | $445 | $21 |
| Mirtazapine | 15 | $420 | $28 |
| Morphine Sulfate Er | 15 | $419 | $28 |
| Dexamethasone | 15 | $331 | $22 |
| Prednisone | 30 | $266 | $9 |
| Potassium Chloride | 17 | $155 | $9 |
| Gabapentin | 12 | $130 | $11 |
| Amlodipine Besylate | 14 | $79 | $6 |
2019: 7 drugs
| Xarelto | 12 | $7,767 | $647 |
| Sodium Chloride | 27 | $650 | $24 |
| Ondansetron | 28 | $521 | $19 |
| Oxycodone-Acetaminophen | 19 | $362 | $19 |
| Prochlorperazine Maleate | 39 | $358 | $9 |
| Anastrozole | 15 | $155 | $10 |
| Hydrocodone-Acetaminophen | 13 | $105 | $8 |
2017: 5 drugs
| Zytiga | 11 | $110,800 | $10,073 |
| Tamoxifen Citrate | 18 | $299 | $17 |
| Anastrozole | 20 | $130 | $7 |
| Letrozole | 12 | $75 | $6 |
| Prednisone | 12 | $44 | $4 |
2016: 2 drugs
| Anastrozole | 28 | $245 | $9 |
| Tamoxifen Citrate | 11 | $201 | $18 |
2015: 1 drug
| Anastrozole | 16 | $129 | $8 |
2014: 6 drugs
| Atorvastatin | 14 | $735 | $53 |
| Clopidogrel | 17 | $616 | $36 |
| Metformin | 28 | $253 | $9 |
| Lisinopril | 31 | $106 | $3 |
| Simvastatin | 22 | $101 | $5 |
| Amlodipine Besylate | 12 | $40 | $3 |
2013: 2 drugs
| Simvastatin | 14 | $76 | $5 |
| Lisinopril | 16 | $56 | $3 |
Money from drug and device companies
$43 in 2025
| 2025 | 1 | 1 | None | $43 |
| 2022 | 2 | 3 | None | $82 |
| 2021 | 3 | 5 | None | $105 |
| 2020 | 2 | 4 | None | $175 |
| 2019 | 4 | 5 | None | $234 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Enhertu | $43 | 1 payment
|
See the published payment
| AstraZeneca Pharmaceuticals LP | Education · 2025-11-19 | Enhertu | $43 |
See earlier years (2022, 2021, 2020, 2019)
2022: $82
| Pfizer | Ibrance | $64 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Opdivo | $18 | 1 payment
|
2021: $105
| Pharmacyclics LLC An AbbVie | Imbruvica | $54 | 2 payments
|
| Pfizer | Inlyta | $39 | 2 payments
|
| Janssen Biotech | Erleada | $13 | 1 payment
|
2020: $175
| Genentech USA | Avastin | $136 | 1 payment
|
| Pfizer | Xalkori | $38 | 3 payments
|
2019: $234
| Genentech USA | Avastin | $127 | 1 payment
|
| Intuitive Surgical | Da Vinci Surgical System | $61 | 1 payment
|
| Novartis Pharmaceuticals | Promacta | $33 | 2 payments
|
| Pfizer | Braftovi | $13 | 1 payment
|
Professional record
- NPI
- 1417247842
- Licence
- CA A155292California A155292: Current · expires 2028-03-31
- Trained
- University of California, Geffen School of Medicine, 2011
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Medical oncology (207RX0202X)
- Mailing address
- 2505 Hospital Dr Ste 1, Mountain View, CA, 94040
- NPI first listed
- 2011-04-19
- NPI last updated
- 2024-09-05
- NPI record certified
- 2024-09-05
This is when the NPI record was last certified, not a medical board exam.